SCHEMBL18214403

SCHEMBL18214403

C=C(OS(=O)(=O)c1ccc(Cc2ccc(S(=O)(=O)OC(=C)C(=O)OCC)cc2)cc1)C(=O)OCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
GAA P10253 4/20 0.39
HPGD P15428 4/20 0.39
KDM4E B2RXH2 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MAPT P10636 3/20 0.38
KMT2A Q03164 5/20 0.37
POLB P06746 2/20 0.37
NPSR1 Q6W5P4 3/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CASP1 P29466 1/20 0.36
LMNA P02545 5/20 0.35
MEN1 O00255 3/20 0.35
HTT P42858 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8943095 0.88 ALDH1A1 (0.46) ALDH1A1GAAKDM4ESMN1; SMN2NPC1
SCHEMBL18214402 0.88 ALDH1A1 (0.40) ALDH1A1GAAHPGDMAPTKMT2A
SCHEMBL18214409 0.85 SMN1; SMN2 (0.43) ALDH1A1GAAHPGDSMN1; SMN2NPC1
SCHEMBL18203192 0.85 ALDH1A1 (0.50) ALDH1A1GAAHPGDSMN1; SMN2NPC1
SCHEMBL21980299 0.83 TDP1 (0.42) ALDH1A1GAASMN1; SMN2MAPTKMT2A
SCHEMBL18214411 0.83 ALDH1A1 (0.39) ALDH1A1GAAHPGDSMN1; SMN2NPC1
SCHEMBL18214408 0.82 GAA (0.48) ALDH1A1GAAMAPTKMT2APOLB
SCHEMBL18214405 0.81 ALDH1A1 (0.42) ALDH1A1GAAHPGDSMN1; SMN2NPC1
SCHEMBL20925339 0.78 ALDH1A1 (0.33) ALDH1A1GAAHPGDKDM4ESMN1; SMN2
SCHEMBL29137837 0.76 ALDH1A1 (0.41) ALDH1A1GAASMN1; SMN2KMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10982071-B2 Sulfonic acid esters as regulators in radical polymerization reactions IVOCLAR VIVADENT AG (LI) 2021-04-20 US disclosed
US-10736820-B2 Materials which can be cured by chain transfer polymerization IVOCLAR VIVADENT AG (LI) 2020-08-11 US disclosed
EP-3292157-B1 SULFONIC ACID ESTER AS REGULATOR IN RADICAL POLYMERIZATION REACTIONS IVOCLAR VIVADENT AG (LI) 2019-04-24 EP disclosed
EP-3090722-B1 DENTAL MATERIALS WHICH CAN BE HARDENED BY CHAIN-TRANSFER POLYMERIZATION IVOCLAR VIVADENT AG (LI) 2019-01-09 EP disclosed
US-20180142082-A1 SULFONIC ACID ESTERS AS REGULATORS IN RADICAL POLYMERIZATION REACTIONS IVOCLAR VIVADENT AG (LI) 2018-05-24 US disclosed
US-20180142082-A1 SULFONIC ACID ESTERS AS REGULATORS IN RADICAL POLYMERIZATION REACTIONS IVOCLAR VIVADENT AG (LI) 2018-05-24 US disclosed
WO-2016177680-A1 DENTAL MATERIALS THAT CAN BE CURED VIA CHAIN TRANSMISSION POLYMERISATION IVOCLAR VIVADENT AG (LI) 2016-11-10 WO disclosed
WO-2016177677-A1 SULFONIC ACID ESTERS AS REGULATORS IN RADICAL POLYMERIZATION REACTIONS IVOCLAR VIVADENT AG (LI) 2016-11-10 WO disclosed
EP-3091037-A1 SULFONIC ACID ESTER AS REGULATOR IN RADICAL POLYMERIZATION REACTIONS Ivoclar Vivadent AG (LI) 2016-11-09 EP disclosed
EP-3090722-A1 DENTAL MATERIALS WHICH CAN BE HARDENED BY CHAIN-TRANSFER POLYMERIZATION Ivoclar Vivadent AG (LI) 2016-11-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10736820-B2 Materials which can be cured by chain transfer polymerization H1-10, CNOT1, C1S ALDH1A1 1370/4885GAA 2564/4885HPGD 394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.